Ranbaxy signs deal with CD Pharma for Inersan

New Delhi, March 19th 2008 : According to reports Ranbaxy Laboratories has entered into an exclusive marketing agreement for India and Nepal with CD Pharma for Inersan, a patented probiotic preparation.

Inersan is used for the treatment of dental aliments like periodontitis, gingivitis and halitosis. According to a release issued by Ranbaxy, there is no drug available for the treatment of these dental problems in the country.

Watch Video

OneIndia News